Areca nut in pathogenesis of oral submucous fibrosis: revisited
- PMID: 20376683
- DOI: 10.1007/s10006-010-0219-8
Areca nut in pathogenesis of oral submucous fibrosis: revisited
Abstract
Background: Oral submucous fibrosis is a disease due to a chronic, insidious change in fibro-elasticity, characterized by burning sensation in the oral cavity, blanching, and stiffening of the oral mucosa and oropharynx leading to trismus and inability to open the mouth. The symptoms and signs depend on the progression of the lesions and number of affected sites. It is predominantly seen in Indians and other Asians. Once the disease has developed, there is neither regression nor any effective treatment. It is considered as a pre-malignant stage of oral cancer, and the reported risk of malignant transformation varies from 2.3-7.6%.
Conclusions: The common etiological factor considered for this unremitting disease is use of areca nut; however, the precise mechanism still remains elusive and controversial. A wide range of treatment consisting of drugs, surgical therapy, and physiotherapy have been attempted till date, with varying degrees of benefit, but none of them have proved to be a cure for this disease. This field remains open for clinical trials and research. This paper aims to give an overview on the role of areca nut in the pathogenesis and malignant potential of oral submucous fibrosis.
Similar articles
-
Management of oral submucous fibrosis: an overview.Oral Maxillofac Surg. 2010 Sep;14(3):133-42. doi: 10.1007/s10006-010-0209-x. Oral Maxillofac Surg. 2010. PMID: 20177949 Review.
-
Oral submucous fibrosis: a clinicopathologic review of 205 cases in Indians.Oral Maxillofac Surg. 2011 Mar;15(1):15-9. doi: 10.1007/s10006-010-0225-x. Oral Maxillofac Surg. 2011. PMID: 20414694
-
Oral submucous fibrosis: An update on pathophysiology of malignant transformation.J Oral Pathol Med. 2017 Jul;46(6):413-417. doi: 10.1111/jop.12582. Epub 2017 May 6. J Oral Pathol Med. 2017. PMID: 28391621 Review.
-
Oral squamous cell carcinoma arising in background of oral submucous fibrosis: a clinicopathologically distinct disease.Head Neck. 2013 Oct;35(10):1404-9. doi: 10.1002/hed.23143. Epub 2012 Sep 13. Head Neck. 2013. PMID: 22972608
-
High risk of malignant transformation of oral submucous fibrosis in Pakistani females: A potential national disaster.J Pak Med Assoc. 2016 Nov;66(11):1362-1366. J Pak Med Assoc. 2016. PMID: 27812049
Cited by
-
Oral Submucous Fibrosis: A Review on Etiopathogenesis, Diagnosis, and Therapy.Int J Mol Sci. 2019 Jun 16;20(12):2940. doi: 10.3390/ijms20122940. Int J Mol Sci. 2019. PMID: 31208114 Free PMC article. Review.
-
Serum Iron and Haemoglobin Estimation in Oral Submucous Fibrosis and Iron Deficiency Anaemia: A Diagnostic Approach.J Clin Diagn Res. 2016 Dec;10(12):ZC54-ZC58. doi: 10.7860/JCDR/2016/21481.9077. Epub 2016 Dec 1. J Clin Diagn Res. 2016. PMID: 28209005 Free PMC article.
-
Association of betel nut with carcinogenesis: revisit with a clinical perspective.PLoS One. 2012;7(8):e42759. doi: 10.1371/journal.pone.0042759. Epub 2012 Aug 13. PLoS One. 2012. PMID: 22912735 Free PMC article.
-
Small Molecule "Silmitasertib" Repurposed as Inhibitor of Transforming Growth Factor Beta 1 for the Development of Therapeutics for Oral Submucous Fibrosis.Biomed Res Int. 2021 Apr 1;2021:6631848. doi: 10.1155/2021/6631848. eCollection 2021. Biomed Res Int. 2021. PMID: 33869629 Free PMC article.
-
A clinic-pathological research explored the significance of ascorbic acid and iron levels in serum and saliva in premalignant disorder patients at Kanpur, Uttar Pradesh.Natl J Maxillofac Surg. 2024 Jan-Apr;15(1):131-135. doi: 10.4103/njms.njms_470_21. Epub 2024 Mar 19. Natl J Maxillofac Surg. 2024. PMID: 38690244 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources